Haemophilia B mutations in Sweden:: a population-based study of mutational heterogeneity

被引:61
作者
Ljung, R [1 ]
Petrini, P
Tengborn, L
Sjörin, E
机构
[1] Univ Lund, Univ Hosp, Dept Paediat, Paediat Clin, SE-20502 Malmo, Sweden
[2] Univ Lund, Univ Hosp, Dept Coagulat Disorders, SE-20502 Malmo, Sweden
[3] Karolinska Hosp, Dept Paediat, S-10401 Stockholm, Sweden
[4] Karolinska Hosp, Dept Coagulat Disorders, S-10401 Stockholm, Sweden
[5] Sahlgrenska Univ Hosp, Dept Coagulat Disorders, Gothenburg, Sweden
关键词
haemophilia B; factor IX; mutation; inhibitor; mutation frequency;
D O I
10.1046/j.1365-2141.2001.02759.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present series comprises all families (n = 77) with haemophilia B in Sweden and may be considered to be representative for the purposes of a population-based study of mutational heterogeneity, The 77 families (38 severe, 10 moderate, 29 mild) had 51 different mutations in total. Thirteen families had total, partial or small deletions, two had mutations in the promoter, eight families had splice site mutations, 14 had nonsense and the remaining 41 had missense mutations. Ten of the mutations, all C -->T or G -->A, recurred in 1-6 other families. Using haplotype analysis of seven polymorphisms in the factor IX (FIX) gene, we found that the 77 families carried 65 unique, independent mutations, Of the 48 families with severe or moderate haemophilia, 23 (48%) had a sporadic case of haemophilia compared with 31 families out of 78 (40%) in the whole series, Five of those 23 sporadic cases carried de novo mutations, 11 out of 23 of the mothers were proven carriers and, in the remaining seven families, it was not possible to determine carriership. Eleven of the 48 patients (23%) with severe haemophilia B developed inhibitors and all of them had deletions or nonsense mutations. Thus, 11 out of 37 (30%) patients with severe haemophilia B as a result of deletion/nonsense mutations developed inhibitors compared with 0 out of 11 patients with missense mutations. The ratio of male to female mutation rates was 5.3 and the overall mutation rate was 5.4 x 10(-6) per gamete per generation.
引用
收藏
页码:81 / 86
页数:6
相关论文
共 37 条
[1]  
Attali O, 1999, THROMB HAEMOSTASIS, V82, P1437
[2]  
Becker J, 1996, AM J HUM GENET, V58, P657
[3]   A NEW MSPI RESTRICTION FRAGMENT LENGTH POLYMORPHISM IN THE HEMOPHILIA-B LOCUS [J].
CAMERINO, G ;
OBERLE, I ;
DRAYNA, D ;
MANDEL, JL .
HUMAN GENETICS, 1985, 71 (01) :79-81
[4]   CG DINUCLEOTIDE TRANSITIONS IN THE FACTOR-IX GENE ACCOUNT FOR ABOUT HALF OF THE POINT MUTATIONS IN HEMOPHILIA-B PATIENTS - A SEATTLE SERIES [J].
CHEN, SH ;
ZHANG, M ;
LOVRIEN, EW ;
SCOTT, CR ;
THOMPSON, AR .
HUMAN GENETICS, 1991, 87 (02) :177-182
[5]  
COOPER DN, 1990, HUM GENET, V85, P55
[6]  
DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P1528
[7]  
FERRARI N, 1986, REV BRAS GENET, V9, P87
[8]   Haemophilia B: database of point mutations and short additions and deletions - eighth edition [J].
Giannelli, F ;
Green, PM ;
Sommer, SS ;
Poon, MC ;
Ludwig, M ;
Schwaab, A ;
Reitsma, PH ;
Goossens, M ;
Yoshioka, A ;
Figueiredo, MS ;
Brownlee, GG .
NUCLEIC ACIDS RESEARCH, 1998, 26 (01) :265-268
[9]  
GIANNELLI F, 1984, LANCET, V1, P239
[10]  
GIANNELLI F, 1983, NATURE, V303, P181, DOI 10.1038/303181a0